Heterocyclic compounds as PARG inhibitors
TW202635644APending Publication Date: 2026-09-01SYNNOVATION THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114144076
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-28
- Filing Date
- 2025-11-12
- Publication Date
- 2026-09-01
Abstract
The present application provides heterocyclic compounds that modulate the activity of poly(ADP-ribose) glycohydrolase (PARG), which are useful in the treatment of various diseases, including cancer.
Need to check novelty before this filing date? Find Prior Art